Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 2 ... compared to addition of treatment with JANUVIA (sitagliptin) 100mg per day in reducing glycosylated hemoglobin level (HbA1c) from baseline. In October, the company also announced results ...
2009 OCT 19 ... added to metformin, demonstrated significant mean reductions in the primary endpoint, glycosylated hemoglobin level (HbA1c) and in the secondary endpoint, fasting plasma glucose (FPG) in patients ...
2009 NOV 18 ... The association remained significant after adjusting for maternal pregnancy-glycosylated hemoglobin. Fetal genotypes at the CDKAL1 and SLC30A8 loci were not associated with birth weight in ...
2009 NOV 23 ... The rest were more traditional measures including (4) fasting plasma Glucose (FPG), (5) glycosylated hemoglobin level (HbA1c), (6) fasting insulin levels (IRI), (7) average systolic blood pressure, ...
2009 NOV 23 ... vs 15.0 mm Hg, P<.001) and in those with higher serum glucose levels (P <.001), glycosylated hemoglobin concentrations (P <.001), total cholesterol levels (P=.001), triglyceride levels ...
2009 NOV 1 ... proteinuria assessed (85% vs 74% in 2000), foot examinations performed (90% vs 86%), glycosylated hemoglobin levels measured (94% vs 87%), lipids measured (81% vs 70%), aspirin use recommended (67% ...
2009 NOV 2 ... 493 patients 18-80 years old with inadequate glycemic control after stabilization (i.e., glycosylated hemoglobin [HbA(1c)] 7.0-10.0%) despite ongoing treatment with a TZD were randomly assigned (2:2:1) ...
2009 NOV 23 ... exenatide and insulin glargine. Modeled treatment effects included reductions in glycosylated hemoglobin (HbA1c ) by -0.99% and -1.07% and in body mass index (BM 1) by -0.80 and +0.55 kg/m(2) ...
2009 NOV 9 ... baseline to 12 to 16 weeks of treatment. Secondary efficacy end points were changes in glycosylated hemoglobin (HbA(1c)), fasting PG (FPG), postprandial PG increment (averaged over breakfast, lunch, ...
2009 NOV 16 ... determinants that predict a worse carotid IMT. Carotid IMT increased with higher glycosylated hemoglobin (HbA1c ) levels and longer duration of diabetes. Regression modeling showed that HbA1c ...
2009 NOV 9 ... 20%. Elevated serum glucose, nonhigh-density lipoprotein, triglycerides, homocysteine, glycosylated hemoglobin as well as large vessel atherosclerotic stroke mechanism were more frequent in high ...
2009 NOV 9 ... age, duration of diabetes, duration of medical treatment, dose of rosiglitazone, serum glycosylated hemoglobin and total testosterone Values. The use of rosiglitazone is associated with an increased ...
2009 NOV 1 ... (PA) requirement by the Leumit Health Fund of Israel resulted in inferior rates of glycosylated hemoglobin (A1C) testing among new users of expensive diabetes medications. Electronic patient ...
2009 NOV 2 ... or placebo, for 16 weeks of treatment. The primary efficacy endpoint will be change in glycosylated hemoglobin (HbA(1c)) in patients with type 2 DM and change in low-density lipoprotein-cholesterol ...
2009 OCT 12 ... levels in type 2 diabetic Omani patients, and to find the relation between Mg levels and glycosylated hemoglobin (HbA1c ), body mass index (BMI), and age of the patient. This work was carried out at ...
2009 NOV 23 ... hypoglycemia were enrolled. All used multiple daily insulin injections, and the glycosylated hemoglobin level was 8.4 +/- 0.3%. After a month of gathering hypoglycemia information for baseline ...
